Synonyms: KPT-8602 | KPT8602
Compound class:
Synthetic organic
Comment: Eltanexor (KPT-8602) is a second-generation, orally bioavailable, selective inhibitor of the nuclear export protein XPO1, that works in the same way as its first-in-class relation selinexor. In comparison to selinexor, eltanexor exhibits much lower brain penetration, and this appears to reduce the central nervous system-mediated side effects of anorexia and weight loss detected with selinexor therapy [1]. Eltanexor is being investigated for therapeutic antineoplastic potential [1-3].
|
|
Classification | |
Compound class | Synthetic organic |
IUPAC Name |
(E)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-2-pyrimidin-5-ylprop-2-enamide |
International Nonproprietary Names | |
INN number | INN |
10496 | eltanexor |
Synonyms |
KPT-8602 | KPT8602 |
Database Links | |
CAS Registry No. | 1642300-52-4 (source: WHO INN record) |
GtoPdb PubChem SID | 375973225 |
PubChem CID | 86345880 |
Search Google for chemical match using the InChIKey | JFBAVWVBLRIWHM-AWNIVKPZSA-N |
Search Google for chemicals with the same backbone | JFBAVWVBLRIWHM |
Search PubMed clinical trials | eltanexor |
Search PubMed titles | eltanexor |
Search PubMed titles/abstracts | eltanexor |
UniChem Compound Search for chemical match using the InChIKey | JFBAVWVBLRIWHM-AWNIVKPZSA-N |
UniChem Connectivity Search for chemical match using the InChIKey | JFBAVWVBLRIWHM-AWNIVKPZSA-N |